Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

INTRODUCTION: This double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous epoetin alfa-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease (ESKD) and anemia who were receiving epoetin a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Kidney Int Rep
Asıl Yazarlar: Fishbane, Steven, Spinowitz, Bruce S., Wisemandle, Wayne A., Martin, Nancy E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734106/
https://ncbi.nlm.nih.gov/pubmed/31517143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.05.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller